通过与胺共享的机制,psilocybin的治疗潜力超出了迷幻的范围
Dongsun Park1,2, Gwangho Lee3, Won-Gyu Lee4
1Department of Biomedical and Pharmaceutical science, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
胺类药物和 псилоцибин通过不同的途径增强大脑可塑性,为抑郁症提供快速缓解. 它们共同的BDNF-TrkB信号传递促进了持久的抗抑郁作用,指导了未来的药物开发.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 大型抑郁症 (MDD) 往往对传统抗抑郁药物反应不佳.
- 快速起作用的药物,如胺和 псилоцибин,为MDD提供了新的治疗途径.
- 这些药物在几个小时内提供症状缓解,与传统治疗不同.
研究的目的:
- 审查关于MDD的胺和西的临床和临床前研究结果.
- 为了比较它们的分子目标,电路级效应和下游路径.
- 为下一代快速起作用抗抑郁药的开发提供信息.
主要方法:
- 最近关于胺和西的临床和临床前研究的综合.
- 对分子点的分析,包括NMDA和5-HT2A受体.
- 检查下游的信号通路,如BDNF-TrkB.
主要成果:
- 胺 (NMDA对抗剂) 和 псилоцибин (5-HT2A对抗剂) 增强了突触可塑性.
- 一个共同的机制涉及BDNF-TrkB信号传递,这对旋转生成和突触生成至关重要.
- 5-HT2A受体偏向激素可能会将治疗效果与幻觉分开.
结论:
- 胺类药物和 псилоцибин表现出对抗抑郁药快速作用的重叠和不同的机制.
- 融合的神经营养,谷氨酸和血清的途径是关键.
- 未来的抗抑郁药可能是快速起作用,持久,非幻觉.
更多相关视频
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
相关概念视频
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
